Regulation of BAX and BCL‐2 expression in breast cancer cells by chemotherapy Laura F. GibsonJames FortneyKenneth S. Landreth OriginalPaper Pages: 107 - 117
Successful co‐treatment with LHRH‐agonist for ovarian over‐stimulation and cystic formation in premenopausal tamoxifen exposure Ilan CohenRon TepperYoram Beyth OriginalPaper Pages: 117 - 123
Differentially expressed genes associated with the metastatic phenotype in breast cancer Dawn A. KirschmannElisabeth A. SeftorMary J.C. Hendrix OriginalPaper Pages: 125 - 134
Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases Bernard TêtuJacques BrissonCaty Blanchette OriginalPaper Pages: 135 - 145
Synergistic action of apoptosis induced by eicosapentaenoic acid and TNP‐470 on human breast cancer cells Daigo YamamotoYasuhiko KiyozukaAiro Tsubura OriginalPaper Pages: 147 - 158
Reduced expression of p27Kip1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation Sehwan HanKyeongmee ParkYoung‐Duck Kim OriginalPaper Pages: 159 - 165
Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors Sylvie MénardPatrizia CasaliniM. Ines Colnaghi OriginalPaper Pages: 167 - 175
Down‐regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion Harold L. AschJanet S. WinstonBonnie B. Asch OriginalPaper Pages: 177 - 186
Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT‐B Lesley J FallowfieldSamantha K LeaityDavid Cella OriginalPaper Pages: 187 - 197